Dr. Steven Muntean Corsello, MD

Dr. Corsello practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Corsello's NPI, 1407015944, was assigned on June 9, 2008. Dr. Corsello graduated from Harvard Medical School in 2008. Dr. Corsello's California license number on file is C175410.

Dr. Corsello's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Corsello's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Corsello to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Corsello's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Corsello practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Corsello's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Corsello is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Corsello's licenses on file in 5 states: California, Massachusetts, New Hampshire, New York and Rhode Island.

Dmand AI lists chronic hypertension among the conditions Dr. Corsello treats.

CMS data shows 31 Medicare services from Dr. Corsello across 2 procedure codes in 2024, for 50 Medicare patients. Medicare paid $3,411 for them.

CMS counts 50 Medicare patients who saw Dr. Corsello in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Corsello's median patient age at 64, with 47% women.

In 2024, Dr. Corsello wrote 45 Medicare Part D claims for 14 patients. 84% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $148 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Corsello for performance year 2024, reported as part of a group. Dr. Corsello accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Corsello as offering telehealth.

Dmand AI links 18 papers to Dr. Corsello, published from 2005 to 2023. 2022 was the busiest year, with 3. The most frequent topics are Cell Line, Tumor, Colorectal Neoplasms and Gene Expression Profiling. Dr. Corsello has published most often in Blood. Dr. Corsello's most frequent co-authors are Marios Giannakis, MD, Kimmie Ng, MD and Thomas Adam Abrams, MD.

CMS Open Payments shows 2 general payments to Dr. Corsello from 1 drug or device company in 2023. Consulting fees make up the largest share, 99% of the total. Genentech, Inc. paid the most, $2,535.

Dr. Corsello graduated from Harvard Medical School in 2008.

Dr. Corsello is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.